Pubertal Timing, Androgens, and Obesity Phenotypes in Women at Midlife
Pubertal Timing, Androgens, and Obesity Phenotypes in Women at Midlife
复制标题
DOI:
10.1210/jc.2012-1972
复制
发表时间:
2012-10-01
影响因子:
5.8
通讯作者:
Cedars, Marcelle I.
中科院分区:
文献类型:
--
作者:
Bleil, Maria E.;Appelhans, Bradley M.;Cedars, Marcelle I.
Context: Individuals with metabolically healthy or benign obesity vs. unhealthy or at risk obesity have been distinguished; however, the predisposing factors for developing these phenotypes are poorly understood.Objective: Our objective was to examine pubertal timing marked by menarcheal age in relation to at-risk obese, benign obese, and healthy normal-weight phenotypes at midlife and to characterize the potential role of androgens, marked by the free androgen index (FAI), in accounting for any associations between menarcheal age and obesity phenotype.Design: The study was cross-sectional.Setting and Participants: Participants included a multiethnic community sample of 989 premenopausal women ages 25-45 yr (mean = 35.2 yr; SD = 5.5 yr).Main Outcome Measure: Membership in at-risk obese, benign obese, and healthy normal-weight groups was defined by body mass index and number of metabolic syndrome components.Results: With each 1-yr increase in menarcheal age, the probability of having the at-risk obese compared with the healthy normal-weight phenotype decreased by 22%. This association attenuated when FAI was covaried, suggesting androgen levels may account for this association. In addition, higher FAI was independently related to having the at-risk obese compared with the healthy normal-weight phenotype as well as having the at-risk compared with the benign obese phenotype (all P < 0.05).Conclusions: Younger menarcheal age is associated with having the metabolically unhealthy obesity phenotype compared with the healthy normal-weight phenotype at midlife. This relation may be driven by levels of bioavailable androgens, which were especially elevated among women with the at-risk obesity phenotype. (J Clin Endocrinol Metab 97: E1948-E1952, 2012)